Results 141 to 150 of about 72,493 (257)
The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases
Arthritis Care &Research, Volume 78, Issue 10, Page 1449-1466, October 2026.Objective A data‐driven and expert/patient consensus‐based project to develop a revised Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI) is under way supported by SLICC, ACR, and the Lupus Foundation of America. Our objective is to report the item generation and reduction phase results
Burak Kundakci +25 more
wiley +1 more source
Sensorimotor polyneuropathy and foot-drop as result of a prostate cancer paraneoplastic syndrome
, 2013 John J Bodkin,1 Michael Duff,1,2 Phillip J Seereiter Jr,3 K Kent Chevli1,31State University of New York School of Medicine and Biomedical Sciences Department of Urology, Buffalo; 2Cancer Care of Western New York, Cheektowaga; 3Western New York Urology ...
Bodkin JJ +3 more
core
POEMS Syndrome: 2026 Update on Diagnosis, Risk‐Stratification, and Management
American Journal of Hematology, Volume 101, Issue 10, Page 2632-2651, October 2026.ABSTRACT Disease Overview POEMS syndrome is a life‐threatening syndrome due to an underlying plasma cell neoplasm. The major criteria for the syndrome are polyneuropathy, clonal plasma cell disorder (PCD), sclerotic bone lesions, elevated vascular endothelial growth factor, and the presence of Castleman disease.
Angela Dispenzieri
wiley +1 more source
Gephyrin Neurological Autoimmunity
Annals of Neurology, Volume 100, Issue 4, Page 781-787, October 2026.Gephyrin is a postsynaptic scaffold protein essential for inhibitory neurotransmission. Gephyrin‐immunoglobulin G (IgG) was reported, decades ago, in a single case of paraneoplastic stiff‐person‐like syndrome, but its broader clinical relevance remains unknown.
Maria Chiara Pantuliano +10 more
wiley +1 more source
Chemotherapy Induced Toxic Polyneuropathy in Cancer Patients
, 2016 Amaç: Kanser ilaçlarının toksik etkilerine bağlı polinöropatilerin gelişme oranı ilaçlara göre değişkenlik göstermektedir. Bu çalışmada, taksan ve platin grubu kemoterapi alan hastalarda, ilaca bağlı toksik polinöropati gelişimi oranını belirleme ...
core
British Journal of Clinical Pharmacology, Volume 92, Issue 10, Page 3333-3353, October 2026.Chronic pain represents a complex debilitating condition that extends beyond the protective function of physiological pain, often persisting as an independent disease entity. Chronic primary and secondary pain syndromes reflect a multifaceted continuum involving nociceptive, neuropathic and nociplastic mechanisms.
Stefania Nobili +6 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 10, October 2026.ABSTRACT Idiopathic multicentric Castleman disease (TAFRO subtype) can mimic common differentials. High suspicion is required for chronic systemic symptoms and generalized lymphadenopathy. As fine‐needle aspiration is often non‐diagnostic, early excisional biopsy is important.
Divita Rohatgi +3 more
wiley +1 more source
Journal of Magnetic Resonance Imaging, Volume 64, Issue 4, Page 1077-1088, October 2026.ABSTRACT Background Differentiating demyelinating from axonal polyneuropathies helps for accurate diagnosis and treatment. However, the current clinical tools lack sensitivity to confirm demyelination in peripheral nerves, particularly for proximal nerves.
Jesus E. Fajardo +8 more
wiley +1 more source
Muscle &Nerve, Volume 74, Issue 4, Page 1220-1229, October 2026.ABSTRACT Introduction/Aims Lumbosacral plexopathy (LSP) results from a spectrum of etiologies and can cause substantial functional impairment. Limited data exist on the relative distribution of etiologies and outcomes across broad tertiary‐care cohorts spanning multiple causes of LSP.
Bradley Ong +4 more
wiley +1 more source